| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $675.4M | +8.8% |
| R&D Expense | $75.6M | +5.6% |
| SG&A Expense | $132.2M | -0.2% |
| Operating Income | $2.4M | +107.9% |
| Pre-tax Income | -$44.0M | +31.8% |
| Income Tax | $1.6M | +135.0% |
| Net Income | -$45.6M | +23.7% |
| EPS (Basic) | -$0.24 | +22.6% |
| EPS (Diluted) | -$0.24 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $92.6M | -0.0% |
| Accounts Receivable | $45.4M | -5.4% |
| Current Assets | $180.1M | -0.2% |
| Total Assets | $1.52B | -4.6% |
| Current Liabilities | $117.4M | +11.7% |
| Long-term Debt | $532.2M | -0.8% |
| Total Liabilities | $692.0M | +1.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $104.6M | +61.4% |
| Capital Expenditures | $3.0M | +18.4% |
| Investing Cash Flow | -$38.0M | -110.3% |
| Financing Cash Flow | -$66.6M | -40.8% |
| Free Cash Flow | $101.6M | +63.2% |
| +22.6% |
| Stockholders' Equity |
| $826.0M |
| -8.9% |